SCHEMBL8306711

SCHEMBL8306711

Cn1nc(Cl)c(C(=O)O)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPK1 P28482 1/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP2C9 P11712 2/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 1/20 0.35
POLB P06746 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.34
CYP3A4 P08684 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3180576 0.98 L3MBTL1 (0.47) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL3180569 0.83 L3MBTL1 (0.45) L3MBTL1ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL13784463 0.83 L3MBTL1 (0.45) L3MBTL1ALDH1A1SMN1; SMN2KDM4ECYP1A2
SCHEMBL1335837 0.81 L3MBTL1 (0.60) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL3981132 0.81 KDM4E (0.43) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL30984209 0.81 L3MBTL1 (0.44) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL20709966 0.79 KDM4E (0.36) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
Hydrochloric Acid SCHEMBL8760435 0.79 L3MBTL1 (0.58) L3MBTL1ALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL20709965 0.79 L3MBTL1 (0.42) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT
SCHEMBL20027637 0.79 L3MBTL1 (0.42) L3MBTL1ALDH1A1SMN1; SMN2MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0350176-B1 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL IND LTD (JP) 1995-08-30 EP claimed
EP-0350176-A2 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1990-01-10 EP claimed
JP-7304747-A None JP disclosed
US-20230167094-A1 H4 ANTAGONIST COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2023-06-01 US disclosed
US-11339130-B1 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2022-05-24 US disclosed
US-10934261-B2 Calpain modulators and therapeutic uses thereof BLADE THERAPEUTICS, INC. (US) 2021-03-02 US disclosed
US-10894776-B2 2021-01-19 US disclosed
CN-1058490-C Tetrazolinone derivatives BAYER AGROCHEM KK (JP) 2000-11-15 CN disclosed
EP-0695748-B1 Tetrazolinone herbicides BAYER AGROCHEM KK (JP) 1999-05-06 EP disclosed
US-5589439-A HERBICIDES NIHON BAYER AGROCHEM K.K. (JP) 1996-12-31 US disclosed
US-5545608-A EFFECTIVE AGAINST PADDY WEEDS WHILE SAFE FOR RICE PLANTS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1996-08-13 US disclosed
EP-0695748-A1 Tetrazolinone herbicides NIHON BAYER AGROCHEM K.K. (JP) 1996-02-07 EP disclosed
JP-H07304747-A 3,5-DICHLORO-4-CYANO-1-METHYLPYRAZOLE AND PRODUCTION THEREOF NISSAN CHEM IND LTD 1995-11-21 JP disclosed
EP-0350176-B1 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL IND LTD (JP) 1995-08-30 EP disclosed
EP-0638555-A1 PYRAZOLEGLYCOLAMIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1995-02-15 EP disclosed
US-5202442-A Process for preparing pyrazolecarboxylic acid compounds NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1993-04-13 US disclosed
US-5053517-A PROCESS FOR PREPARING PYRAZOLECARBOXYLIC ACID COMPOUNDS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1991-10-01 US disclosed
EP-0350176-A2 Method for preparing pyrazolecarboxylic acid and derivatives NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1990-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934261-B2 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 L3MBTL1 3522/4885ALDH1A1 4193/4885SMN1; SMN2 200/4885
US-10894776-B2 CAPNS1, CAPN9, CAPN2 L3MBTL1 4453/4885ALDH1A1 4421/4885SMN1; SMN2 263/4885
US-11339130-B1 Calpain modulators and therapeutic uses thereof CAPNS1, CAPN9, CAPN1 L3MBTL1 3522/4885ALDH1A1 4193/4885SMN1; SMN2 200/4885
US-20230167094-A1 H4 ANTAGONIST COMPOUNDS HRH4, HRH3, HRH2 L3MBTL1 2259/4885ALDH1A1 3149/4885SMN1; SMN2 3911/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.